COMMUNIQUÉS West-GlobeNewswire

-
Viemed Healthcare Announces First Quarter 2025 Earnings Conference Call Details
22/04/2025 - 22:30 -
UNITY Biotechnology, Inc. Reports First Quarter 2025 Financial Results and Business Updates
22/04/2025 - 22:30 -
STERIS to Host a Conference Call for Fiscal 2025 Fourth Quarter and Full Year Financial Results on May 15, 2025
22/04/2025 - 22:30 -
Natural Mounjaro Recipe for Weight Loss: The Best OTC Tirzepatide Alternative, Slimjaro
22/04/2025 - 22:49 -
Clover Health Announces Changes to Board of Directors
22/04/2025 - 23:00 -
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
22/04/2025 - 23:00 -
AVAVA™ Receives FDA Clearance for Revolutionary Acne Scar Treatment using Focal Point Technology™
22/04/2025 - 17:18 -
Scientific Industries Secures New Funding to Advance its SBI Bioprocessing Division
22/04/2025 - 17:49 -
EssilorLuxottica: Déclaration de transactions sur actions propres
22/04/2025 - 18:00 -
EssilorLuxottica: Disclosure of transactions in own shares
22/04/2025 - 18:00 -
Press release: Sequana Medical announces the Annual and Extraordinary General Meetings of Shareholders on 22 May 2025
22/04/2025 - 18:00 -
Elite Clinical Network and HealthyU Clinics Announce Strategic Partnership to Expand Access to Clinical Research
22/04/2025 - 18:28 -
MULTIMEDIA UPDATE: AVAVA™ Receives FDA Clearance for Revolutionary Acne Scar Treatment using Focal Point Technology™
22/04/2025 - 19:50 -
Cronos Unveils New Spinach® 1.2g Vapes and SOURZ by Spinach® Gummies Enhanced with Rare Cannabinoids
22/04/2025 - 14:00 -
Daxor Corporation to Exhibit at the 45th International Society for Heart and Lung Transplant (ISHLT) Annual Meeting and Scientific Sessions
22/04/2025 - 14:00 -
Catalyst Pharmaceuticals to Report First Quarter 2025 Financial Results on May 7, 2025
22/04/2025 - 14:03 -
SCIENTURE announces manufacturing and supply chain readiness for ArbliTM, (losartan potassium) Oral Suspension, 10mg/mL for a target product launch in July 2025.
22/04/2025 - 14:05 -
Theranica Announces Coverage Policy from the Second Largest U.S. Health Insurer for Its Nerivio® REN Wearable Migraine Treatment, Reaching Access for 80 Million Americans
22/04/2025 - 14:10 -
BlueGenes Partners with Level Care to Revolutionize Medication Management for Union Members
22/04/2025 - 14:15
Pages